Page 5 - Functional Characterization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Functional characterization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Functional Characterization Today - Breaking & Trending Today

UA Little Rock Honors Winners of 2021 Student Research and Creative Works Expo


News
No Comments
The University of Arkansas at Little Rock has selected the winners of the 2021 Student Research and Creative Works Expo.
The annual event features the latest innovative research, service or professional work, and creative projects by the student researchers at UA Little Rock. 
The expo also featured presentations by the 2021 winners of the Signature Experience Awards, which provides students with grants to fund a signature experience, including a research project, creative activity, or community project, to enrich the students’ academic experience at UA Little Rock. 
“In its fourth year, the UA Little Rock Signature Experience has matured into a foundational pillar of undergraduate and graduate student research and creative work with the generous support of the Donaghey Foundation,” said Dr. Jeremy Ecke, director of undergraduate research at UA Little Rock.  ....

United States , Maximilian Holzmueller , Giselle Knowles , Logan Sellen , Lindsey Carl , Andrew Chun , Zach Smith , Landon Dekay , Caleb Lefevre , Mariela Saavendra Duran , Jaelan Nelson , Savannah James , Stuti Chatterjee , Mackenzie Nunnally , Thuy Le , Tripti Shukla , Jeremy Ecke , Awaad Al Sarkhi , Mataya Duncan , Kaleigha Smith , Kajal Desai , Alyia Goudeau , Sarah Carlat , Gabrielle Roberts , Josiah Johnson , Cristie Armstrong ,

NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021


Share:
BELTSVILLE, Md., April 10, 2021 (GLOBE NEWSWIRE) NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today presented preclinical and investigational new drug (IND)-enabling data for NC762 at the American Association for Cancer Research (AACR) Annual Meeting 2021. NC762 is a humanized monoclonal antibody specific for B7-H4 and is being developed for the treatment of cancer.
The research presented by our team reinforces our confidence that NC762, our third program, is a novel immunomedicine with unique anti-tumor properties. We believe it has the potential to provide benefit in multiple oncology indications, particularly in cancers where high B7-H4 expression has been observed, such as breast, ovarian and lung cancers, said Michael Richman, NextCure s president and chief executive officer. We look forward to advan ....

United States , Michael Richman , Emily Wong Macdougall , Timothy Mayer , Exchange Commission , American Association For Cancer Research , Phd Nextcure Inc , Nextcure Inc , American Association , Cancer Research , Annual Meeting , Functional Characterization , Tumor Immune System , Private Securities Litigation Reform Act , Inquiries Timothy Mayer , Chief Operating Officer , Inquiries Emily Wong Macdougall , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் பணக்காரன் , எமிலி வோங் மக்டூகல் , தீமோத்தேயு மேயர் , பரிமாற்றம் தரகு , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , அமெரிக்கன் சங்கம் , புற்றுநோய் ஆராய்ச்சி , ஆண்டு சந்தித்தல் ,